← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 1998Last known activity
Jul 15, 2018
Timeline
1990s
- Jun 1, 1991
Spanish Lung Cancer Group— Founded
Drugs by trial phase (20 distinct, 20 trials)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT03526887Lead sponsorPhase 2Jul 15, 2018
- NCT03526900Lead sponsorPhase 2Jul 7, 2018
- NCT03496766Lead sponsorPhase 2May 7, 2018
- NCT03094286Lead sponsorPhase 2Apr 24, 2017
- NCT03081689Study chairPhase 2Apr 15, 2017
- NCT03081689Lead sponsorPhase 2Apr 15, 2017
- NCT03293680Lead sponsorPhase 2Jan 15, 2017
- NCT02709720Lead sponsorPhase 2Apr 1, 2016
- NCT02273375CollaboratorPhase 3Oct 9, 2014
- NCT02183870CollaboratorPhase 2May 1, 2014
- NCT01562028CollaboratorPhase 2Jun 1, 2012
- NCT01513174Lead sponsorPhase 1/Phase 2Aug 1, 2011
- NCT01088906Study chairPhase 2Jan 1, 2010
- NCT01088906Lead sponsorPhase 2Jan 1, 2010
- NCT00617656Lead sponsorPhase 3Feb 1, 2008
Details
- Founded
- Barcelona, ES Jun 1, 1991
- Last known activity
- Jul 15, 2018